Aziyo biologics co-founder and regenerative medicine pioneer, dr. randy mills, appointed chief executive officer

Silver spring, md., aug. 09, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company, today announced that aziyo co-founder c. randal (randy) mills, ph.d. has assumed the president and chief executive officer role on an on-going basis. dr. mills, who is internationally recognized for his contributions to the field of regenerative medicine, has served as the company's interim ceo since june 2022.
AZYO Ratings Summary
AZYO Quant Ranking